YOUR VOICE IN PUBLIC POLICY TO IMPROVE LIVES 2016 ANNUAL REPORT

YOUR VOICE IN PUBLIC POLICY TO IMPROVE LIVES 2016 ANNUAL REPORT

TABLE OF CONTENTS Message from the Chair...3 2016 TakPAC by the Numbers...4 2016 TakPAC Financial Statement...5 Who Decides Where TakPAC Funds Go?...6 2016 Federal, State and Party Contributions...7 How Did TakPAC Compare to Other Industry PACs in 2016?...10 TakPAC Commitment to Employees...11

MESSAGE FROM THE CHAIR Welcome to TakPAC It is my pleasure to share the TakPAC 2016 Annual Report with you. TakPAC is Takeda s political action committee or PAC a fund used to help elect state and federal lawmakers who share our vision to bring innovative medicines to patients. This is a program driven by the voluntary contributions of eligible Takeda employees. TakPAC is a traditional PAC, not a Super PAC, and as such, is the only legal way for Takeda to provide direct support to all federal and many state candidates who understand our public policy positions related to pharmaceutical innovation, the needs of patients we serve, and matters important our industry. The U.S. government accounts for nearly half of all U.S. healthcare spending, and its policies, legislation, and regulations impact the entire healthcare system. The majority of our country s policymakers have little to no background in medicine or science. We must educate our elected officials on both sides of the aisle and regularly share with them Takeda s point of view on issues affecting our products and therapeutic areas. Takeda, through its Government and External Affairs (GEA) function, helps inform the U.S. debate over healthcare and pharmaceutical innovation at the federal, state and local levels. Within GEA s framework, TakPAC plays a crucial role in these ongoing debates. TakPAC directly supports, in a bipartisan manner, political candidates who understand the importance of the work the biopharmaceutical industry does every day, and helps create an environment where the needs of our patients and our industry can be heard. Because of the important role of TakPAC in our advocacy efforts, Takeda and GEA want you to be fully informed about TakPAC s mission and activities. This report provides a complete accounting of TakPAC s financial performance in 2016, as well as the state and federal candidates and committees that were supported. Our objective is to ensure you know not only who we supported and by how much, but how candidate support decisions are made, who makes them, and why. TakPAC is committed to full transparency and good stewardship of all donations made by employees. On behalf of the entire TakPAC team, I encourage you to learn more about TakPAC. Rick Ascroft 2016 TakPAC Chairman Senior Vice President, Managed Markets and Government Affairs Takeda Pharmaceuticals U.S.A., Inc. 3

177 ELIGIBLE TAKEDA LEADERS PARTICIPATED IN TakPAC OF TakPAC DONORS 81% CONTRIBUTED THROUGH RECURRING PAYROLL DEDUCTION $71,667.41 RAISED THROUGH VOLUNTARY EMPLOYEE CONTRIBUTIONS 19% INCREASE OVER 2015 $90,500 CONTRIBUTED TO 50 STATE & FEDERAL CANDIDATES & COMMITTEES OF STATE & FEDERAL 93.5% CANDIDATES SUPPORTED BY TakPAC WON THEIR ELECTIONS 2016 TakPAC BY THE NUMBERS 4

2016 TakPAC FINANCIAL STATEMENT REVENUE Cash on Hand (1/1/2016) $ 40,546.58 Receipts from Voluntary Employee Donations $ 71,667.41 $ 112,213.99 DISBURSEMENTS Federal Candidates & Political Committees $ 43,000.00 Federal Political Committees $ 30,000.00 State & Local Candidates $ 17,500.00 Operating Expenses (bank fees) $ 1,733.10 $ 92,233.10 Ending Balance (12/31/16) $ 19,980.89 5

WHO DECIDES WHERE TakPAC FUNDS GO? TakPAC Board of Directors CHAIR VICE CHAIR TREASURER ASST. TREASURER TEAM MEMBER TEAM MEMBER RICHARD ASCROFT LAURA CLINE HELEN GIZA PATRICK BUTLER ANDREW KAPLAN SHELLEY STEWART Sr. Vice President, Managed Markets and Government Affairs Head, Policy and Advocacy Government and External Affairs Sr. Vice President and Chief Financial Officer U.S. Business Unit Head, U.S. Tax Vice President, Government and External Affairs Director, Federal Government Affairs Criteria TakPAC Uses to Determine Candidates to Support The candidate s interest or involvement in the pharmaceutical industry and his or her position on key issues affecting Takeda and our patients. The presence of Takeda facilities, employees or major customers in the candidate s district/state. The candidate s leadership and membership on key committees with jurisdiction over legislative issues affecting Takeda and our patients. The candidate s character, integrity and leadership positions. The candidate s financial need and nature of the opposition. Political party affiliation or positions on non-business policy issues are not criteria for candidate support. 6

2016 POLITICAL CONTRIBUTIONS Federal Contributions by Party Candidates Party Amount California Rep. Scott Peters D $5,000 Illinois Rep. Cheri Bustos D $1,000 Rep. Danny Davis D $2,500 Rep. Robert Dold Jr. R $5,000 Rep. Robin Kelly D $1,000 Sen. Mark Kirk R $1,500 Rep. Peter Roskam R $2,500 Rep. John Shimkus R $1,000 Indiana Rep. Susan Brooks R $1,000 Massachusetts Rep. Michael Capuano D $5,000 Rep. Katherine Clark D $2,500 Rep. Joseph Kennedy III D $1,000 Rep. Jim McGovern D $1,000 Rep. Seth Moulton D $2,500 Rep. Richard Neal D $2,500 Minnesota Rep. Erik Paulsen R $1,500 North Carolina Rep. Patrick McHenry R $2,500 Oregon Sen. Ron Wyden D $1,250 Washington Rep. Cathy McMorris Rodgers R $1,500 Sen. Patty Murray D $1,250 Total $43,000 7

2016 POLITICAL CONTRIBUTIONS Federal Political Committees Committee for Hispanic Causes/Building Our Leadership Diversity PAC (CHC BOLD PAC) Amount $5,000 National Republican Congressional Committee $15,000 New Democrat Coalition PAC $5,000 Republican Main Street Partnership PAC $5,000 Total $30,000 Distribution of State and Federal Contributions 8

2016 POLITICAL CONTRIBUTIONS State Contributions by Party Candidates Party Amount Ohio State Rep. Nickie Antonio D $500 State Rep. Heather Bishoff D $500 State Sen. Randy Gardner R $500 State Sen. Lou Gentile D $500 State Rep. Cliff Hite R $500 State Rep. Stephen Huffman R $500 State Sen. Larry Obhof, Jr. R $500 State Rep. Cliff Rosenberger R $1,000 State Rep. Fred Strahorn D $1,000 Texas State Rep. Carol Alvarado D $500 State Rep. Cesar Blanco D $500 State Rep. Cindy Burkett R $500 State Rep. Garnet Coleman D $500 State Rep. Drew Darby R $500 State Sen. Juan Hinojosa D $1,000 State Sen. Lois Kolkhorst R $1,000 State Rep. Eddie Lucio III D $500 State Sen. Robert Nichols R $1,000 State Sen. Charles Perry R $750 State Rep. Four Price R $500 State Rep. Eduardo Rodriguez D $500 State Sen. Charles Schwertner R $1,000 State Sen. Van Taylor R $1,000 State Sen. Kirk Watson D $750 State Sen. Judith Zaffirini D $1,000 State Rep. John Zerwas R $500 TakPAC Contribution Limits $5,000 per primary and general election to a federal candidate s campaign committee. $15,000 per calendar year to each national party committee, such as the Democratic and Republican national, senatorial and congressional campaign committees. $5,000 per year to a federal incumbent s leadership PAC. Leadership PACs may be sponsored by Members of Congress to support other candidates from their political party in order to position themselves for future leadership spots or committee chairmanships. These are separate from a member s campaign committee. $5,000 per year to a state or local party committee. Contribution limits for state and local candidates vary by state laws. Total $17,500 9

2016 POLITICAL CONTRIBUTION RANKINGS HOW DID TakPAC COMPARE TO OTHER INDUSTRY PACS IN 2016? Daiichi Sankyo Eisai Takeda Baxter Boehringer Ingelheim Teva Astellas Bayer Novartis Bristol-Myers Squibb Novo Nordisk GlaxoSmithKline AstraZeneca Johnson & Johnson Sanofi Merck AbbVie Amgen Lilly Pfizer $46,231 $51,433 $71,667 $96,440 $124,084 $128,576 $176,073 $186,301 $211,306 $253,674 $332,328 $380,360 $580,572 $610,078 $652,019 $763,316 $865,410 $884,577 $962,867 $1,515,312 10

TakPAC COMMITMENT TO EMPLOYEES Takeda U.S. engages at all levels of government to ensure we have a voice in the public policy debates that shape and define our company, affect the medicines we develop and market, and impact our ability to serve patients who need them. Many issues drive our political activities.takeda puts patients at the center of everything we do, from our research and development to the launch and sale of products. And rightly so it is our goal to create value to address the unmet medical needs of patients all over the globe. Takeda s U.S. Government and External Affairs (GEA) staff works to educate state and federal elected officials about issues affecting our products and therapeutic areas. GEA also advocates for policies that reflect our patientcentric approach, and to be the voice for patients in public policy discussions on Capitol Hill and in state capitals across the country. Our elected leaders need to know how their decisions and policies will impact the health of patients in their district or state. Takeda s GEA team is committed to a transparent TakPAC and providing information to all employees about the public policy issues that impact our company. We believe it is important for everyone at Takeda to understand the impact, positive and negative, that public policy decisions have on our company and the patients we serve. 11

For more information about TakPAC contact TakPAC@takeda.com One Takeda Parkway TakPAC@TakedaPAC.com www.takedapac.com 2016 ANNUAL REPORT